HHS endorses DEA move to schedule synthetic kratom extracts

HHS endorses DEA move to schedule synthetic kratom extracts

HHS supports the DEA's plan to schedule synthetic kratom extracts like 7-OH as Schedule I drugs to curb widespread abuse.

DEA Revises Proposed Schedule I Restrictions on Kratom Compounds Following New Federal Health Recommendation

The Marijuana Herald - Marijuana news and information Kratom (Mitragyna speciosa). The Drug Enforcement Administration (DEA) is revising its plan to place two kratom-related substances in Schedule I, establishing new concentration thresholds that could allow certain products to remain on the market without being subject to federal controlled substance restrictions. In a Federal Register notice scheduled for publication October 14, the agency out…